A Member of the Cancer Information Network
Cancer Information by State:
  arrow Patient Home   arrow Professional Home   arrow Newsletters   arrow Feedback Survey  
Search:
Medline
CancerConsultants.com
Both
Main Menu
Quick Links
Information by Disease
Cancer News
Conference Coverage
Oncology Stocks
AZN$44.82-0.37 (-0.82%)
NVS$53.13-0.16 (-0.3%)
SNY$37.67-0.01 (-0.03%)
GSK$41.530.06 (0.14%)
click here

Home: Drug Pipeline   Print This Page 


Cancer Consultants Cancer Drug Pipeline



Thyroid Cancer
Drug Name Class Developer Phase
CA4P (combretastatin) Vascular targeting agent Oxigene II
Thyrogen Thyrotropin alfa Genzyme III
For more information contact us at clinicaltrials@cancerconsultants.com

View Drugs in Pipeline By Disease



© 1998-2007 CancerConsultants.com  All Rights Reserved.